This is the authors' abstract. We don't add key points for this paper.
Thymoma is a rare tumor of thymic epithelial cells, accounting for 20–30% of mediastinal tumors. It typically grows slowly and remains confined to the anterior mediastinum, with distant metastasis, such as to the liver, being extremely rare. Liver metastasis and recurrence are particularly rare in type B1 thymoma, making clinical diagnosis more challenging. We report the case of a 60-year-old female who presented with right upper quadrant pain, and imaging revealed a large liver mass. She underwent hepatic bisegmentectomy of S4b and S5 and cholecystectomy, with postoperative pathology confirming hepatic type B1 thymoma. Further evaluation identified a soft tissue mass in the anterior-superior mediastinum, leading to right anterior mediastinal tumor resection and right middle lobectomy, with pathology again confirming type B1 thymoma. The patient received adjuvant chemotherapy. Four years later, tumor recurrence prompted diaphragmatic, paraspinal, and pulmonary nodule resections. Another recurrence occurred after 4 years, necessitating a left hemihepatectomy, which revealed recurrent type B1 thymoma in the liver. She remains recurrence-free during postoperative follow-up. Type B1 thymoma presenting with hepatic metastasis as the initial manifestation is exceedingly rare. Despite its conventionally favorable prognosis, aggressive biological behavior including hematogenous dissemination and multifocal recurrence may occur. Aggressive surgical resection, including repeat hepatectomy in selected patients, may prolong survival. Long-term abdominal surveillance and multidisciplinary management are strongly recommended for such patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: